STOCK TITAN

Fusemachines Warrants 8-K Filings

FUSEW NASDAQ

Every 8-K that Fusemachines Warrants (FUSEW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow FUSEW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FUSEW filings page.

Rhea-AI Summary

Fusemachines Inc. (FUSE) announced that its Board appointed David R. Wells as Consulting Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective August 30, 2026. Wells will serve in this role through a Services Agreement with Atlas Bookkeeping, LLC, where he is the owner.

Under the Services Agreement dated September 1, 2026, Fusemachines will pay Atlas a $14,500 monthly advisory fee for CFO services and a $10,000 one-time retainer. In addition, Wells (or an Atlas designee) will receive monthly grants of 10,000 restricted stock units under the 2025 Omnibus Equity Incentive Plan, each grant vesting in full on the grant date. Either party may terminate the agreement on notice, and it includes confidentiality, mutual non-solicitation, and a planned standard-form indemnification agreement for Wells.

Rhea-AI Summary

Fusemachines Inc. entered into a strategic commercial relationship with Qintess Holding e Participações Ltda. centered on Fusemachines’ Agentic AI products and services. Under a three-year Master License and Services Agreement, Qintess committed to a minimum $6,500,000 of purchases of Fusemachines’ products and services (the Committed Services Spend). In connection with this spend commitment, a Strategic Share Issuance Agreement provides for Fusemachines to issue Qintess up to 1,250,000 shares of common stock in three tranches: 750,000 shares within 10 business days of effectiveness, 250,000 shares on the second anniversary if at least $4,500,000 has been purchased, and a further 250,000 shares on the third anniversary if the full $6,500,000 has been purchased, subject to Qintess’s continued compliance. The shares are being issued in a private placement relying on Section 4(a)(2) of the Securities Act and/or Rule 506(b), and Fusemachines agreed to enter into a Registration Rights Agreement and file a resale registration statement on Form S-1 (or other appropriate form) within 60 days of closing covering the Qintess shares.

Rhea-AI Summary

Fusemachines Inc. announced that Chief Financial Officer Christine Chambers will depart effective August 31, 2026 to pursue new opportunities. She informed the company that her separation is not due to any disagreement with management, the board, or the company’s operations, policies, or practices.

The company has begun a search for a new Chief Financial Officer. Until a successor is appointed, Chief Executive Officer Sameer Maskey will serve on an interim basis as principal financial officer and principal accounting officer as of the separation date. Biographical information for Maskey, age 47, is incorporated by reference from a definitive proxy statement filed on April 27, 2026.

Rhea-AI Summary

Fusemachines Inc. entered into a Securities Purchase Agreement with affiliates of Meteora Capital Partners for an Original Issue Discount Senior Unsecured Convertible Promissory Note with aggregate original principal of $2,500,000 and aggregate purchase price of $2,050,000, reflecting an 18% original issue discount. The zero-coupon Note matures on February 12, 2027, ranks senior in right of payment to existing and future indebtedness subject to permitted indebtedness, and is convertible at the holder’s option into common stock at a fixed $4.20 per share with no ratchets, resets or variable pricing.

Fusemachines also issued a Common Stock Purchase Warrant to purchase up to 2,050,000 common shares at a fixed exercise price of $4.20 per share, without pricing resets, ratchets or other floating-price mechanisms. The Note and Warrant together support a potential investment of up to $10.66 million, including up to approximately 595,238 shares issuable upon Note conversion and additional proceeds of up to $8.61 million if all warrants are exercised for cash. The securities were sold in a private placement relying on Section 4(a)(2) and Rule 506(b) to accredited investors, and Fusemachines agreed to file a registration statement to register for resale the shares underlying the Note and Warrant while investing in growth of its Agentic AI platform.

Rhea-AI Summary

Fusemachines Inc. reported that on July 24, 2026 it received a notification from the Nasdaq Listing Qualifications Department that it is not in compliance with the continued listing requirement to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 for the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(C). Nasdaq’s determination was based on the company’s MVPHS being below $15,000,000 for 30 consecutive business days from June 10, 2026 through July 23, 2026.

The notice has no immediate effect on the listing or trading of Fusemachines’ common stock, which will continue to trade on the Nasdaq Global Market under the symbol FUSE during the compliance period. Under Nasdaq Listing Rule 5810(c)(3)(D), the company has 180 calendar days, until January 20, 2027, to regain compliance, which would occur if its MVPHS closes at or above $15,000,000 for at least 10 consecutive business days. Fusemachines states it intends to actively evaluate and monitor its MVPHS and consider available options, including a possible transfer to the Nasdaq Capital Market, to address the continued listing requirements.

Rhea-AI Summary

Fusemachines Inc. reported that Nasdaq has determined the company has regained compliance with Nasdaq Listing Rule 5450(b)(1)(C), which requires a minimum market value of publicly held shares of $15,000,000. This means Fusemachines’ common stock will continue to be listed on the Nasdaq Global Market.

The company also issued a press release describing its enterprise AI products and services business and reiterating its focus on AI-driven solutions and education initiatives. The update removes the immediate listing-compliance concern that had been pending with Nasdaq.

Rhea-AI Summary

Fusemachines Inc. filed a current report to correct how insider share ownership is reported and to provide an updated ownership table. The company explains that prior Forms 4 for director Timothy Gocher mistakenly treated shares held by Dolma Impact Fund I as his beneficial holdings, even though he serves only as Dolma’s Chief Executive Officer and has no voting or dispositive power over those shares. Amended Forms 4 have now been filed to remove Dolma’s 2,677,293 shares from Mr. Gocher’s reported beneficial ownership.

The filing also presents an updated snapshot of major shareholders and management ownership based on 28,985,302 common shares outstanding as of July 1, 2026. Consilium-related funds and their managers collectively report beneficial ownership stakes of around 38–40% each, while founder and CEO Sameer Maskey holds just over 20%. All current directors and executive officers as a group hold about 23% of the company’s common stock.

Rhea-AI Summary

Fusemachines Inc. held its 2026 Annual Meeting of Stockholders, where stockholders elected three Class I directors, approved an equity incentive plan amendment, and ratified the company’s auditor. Shares of common stock entitled to vote totaled 28,938,266, with 24,896,070 shares present in person or by proxy, representing about 86.0% of eligible shares and establishing a quorum.

Stockholders elected Bharat Krish, Tim Gocher, and Salman Alam as Class I directors. They also approved an amendment to the 2025 Omnibus Equity Incentive Plan to increase the maximum number of shares available to participants by 2,000,000 shares to a total of 3,500,000 shares. In addition, KNAV CPA LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Rhea-AI Summary

Fusemachines Inc. reported changes to its Board of Directors. Effective May 31, 2026, the Board appointed Dr. Julia Hirschberg as a Class II director, serving until the 2027 annual meeting or until a successor is elected and qualified. She also joins the Audit, Compensation, and Nominating and Corporate Governance Committees and becomes chair of the Compensation Committee.

In connection with her appointment, director Sanjay Shrestha resigned from the Board and its committees, with the company stating his resignation was not due to any disagreement on operations, policies, or practices. A related press release highlights Dr. Hirschberg’s extensive background in artificial intelligence research, industry leadership, and AI governance, which the company believes will support its enterprise AI strategy and responsible innovation efforts.

Rhea-AI Summary

Fusemachines Inc. received a notice from Nasdaq that its securities failed to meet the required $50,000,000 Market Value of Listed Securities (MVLS) for the last 30 consecutive business days under Nasdaq Listing Rule 5450(b)(2)(A).

The company’s common stock will continue trading on the Nasdaq Global Market under the symbol FUSE during a 180‑day compliance period, ending on September 23, 2026. Fusemachines can regain compliance if its MVLS is at or above $50,000,000 for at least 10 consecutive business days, and it plans to monitor MVLS and consider options to meet this standard.

Rhea-AI Summary

Fusemachines Inc. entered into an amendment to its existing Forward Purchase Agreement with Meteora-affiliated funds, changing how the deal’s “Termination Price” is set. Previously fixed at $12.00, this price will now reset on the first trading day of each week to the lower of $12.00 or the prior week’s volume-weighted average price, subject to a floor.

Shares and warrants issued under the agreement will be split into two equal tranches, one with a Reset Price Floor of $5.00 and another with a floor of $2.50. In a related warrant amendment, the exercise price on the Meteora shortfall common stock purchase warrant was reduced from $12.00 per share to $10.00 per share.